CASCELLA ROBERT 4

What Happened

• Robert Cascella, a director of Neuronetics, received an award of 36,250 restricted stock units (RSUs) on May 28, 2026 (transaction code A). The filing reports an acquisition at $0.00 (grant of RSUs), total reported value $0 at grant.
• This is a grant/compensation event, not an open-market purchase or sale.

Key Details

• Transaction date and filing: Grant dated 2026-05-28; Form 4 filed 2026-05-29 (appears timely).
• Amount and price: 36,250 RSUs granted at $0.00 (non-cash award).
• Vesting: Per footnote, RSUs vest on the earlier of (a) May 28, 2027 or (b) the reporting person’s Board‑approved separation of service or a change in control, subject to continuous service (Footnote F1).
• Settlement: Each RSU represents the contingent right to one share of common stock upon vesting (Footnote F2).
• Shares owned after transaction: Not specified in the information provided on this filing.
• Filing code: A = Award/Grant. No 10b5‑1, tax‑withholding sale, or late‑filing indication noted.

Context

• RSU grants are a common form of equity compensation for directors and typically convert to actual shares only upon vesting; they do not represent immediate share purchases or sales.
• The ultimate value to the insider depends on Neuronetics’ stock price at settlement; this filing should be viewed as a compensation event rather than a direct signal of insider buying or selling.